Circulogene. CIRCULOGENE is Clinical Laboratory Improvement Amendments (CLIA) and College of American Pathologists (CAP) certified and provides biomarker testing for a broad range of cancers, allowing physicians to match results to specific drugs and clinical trials in just one week.Louis Apicella COO | CTO Laboratory Operations Expertise | AI (Artificial Intelligence) Expertise | Laboratory IT Expertise | P&L Management | Operations Improvements | Strategic Planning Fort...Headquartered in Birmingham, Ala., CIRCULOGENE is an innovative molecular diagnostics company founded and operated by a team of experienced industry executives and skilled molecular diagnostics ...CIRCULOGENE is the most comprehensive blood-based approach to detecting clinically significant tumor DNA/RNA alterations. 25,000 cancer patients have benefited from our innovative, best-in-class liquid biopsy. Our novel approach has created unique liquid biopsy tests which aids oncologists to personalize and monitor the patient’s treatment ...May 25, 2020 · Background: Programmed death ligand-1 (PD-L1) protein expression by immunohistochemical staining (IHC) correlates with response to immune checkpoint inhibitor (ICI) therapies in non-small cell lung cancer (NSCLC). Tumor mutational burden (TMB) is another immune biomarker of ICI response in NSCLC. CIRCULOGENE is Clinical Laboratory Improvement Amendments (CLIA) certified and provides biomarker testing for a broad range of cancers, allowing physicians to match results to specific drugs and...CIRCULOGENE is Clinical Laboratory Improvement Amendments (CLIA) certified and provides biomarker testing for a broad range of cancers, allowing physicians to match results to specific drugs and...CIRCULOGENE's blood-based, gene panel is central to research presented at last weekend's Digestive Disease Week 2023. Speed of delivery resulting from liquid …Sep 28, 2022 · Circulogene is a provider established in Pensacola, Florida operating as a Clinical Medical Laboratory. The NPI number of this provider is 1780308262 and was assigned on September 2022. The practitioner's primary taxonomy code is 291U00000X. The provider is registered as an organization and their NPI record was last updated April 2023. May 28, 2021 A local molecular diagnostic company has received a patent for its proprietary cell-free nucleic acid (CfNA) preparation mythology. Circulogene's patent covers methods for the...Circulogene continues to collaborate with other biotechnology research institutions on additional research projects. Circulogene is the first and only biotechnology company able to enrich circulating cell-free DNA from blood drops for patient-specific monitoring of cancer, achieving maximal output from minimal input.CIRCULOGENE's blood-based, gene panel is central to research presented at last weekend's Digestive Disease Week 2023. Speed of delivery resulting from liquid …CIRCULOGENE, an innovative medical technology company transforming precision medicine through the rapid delivery of actionable biomarkers, shares remarkable results from a revolutionary immunotherapy trial of the experimental drug dostarlimab at the Memorial Sloan Kettering Cancer Center (MSK) in New York.Apr 8, 2022 · 3125 Independence Dr.,, Suite 301 Homewood, Alabama, United States 35209 Phone: 205-278-1600 Fax: 205-278-1651 Email: [email protected] Online Contact: http://circulogene.com/contact/ Website: http://circulogene.com/ GTR Lab ID: 505758, Last updated:2022-04-08 Personnel Director: Chen-Hsiung Yeh, PhD, Lab Associate Director Phone: 205-278-1608 CirculoGene is a biotechnology company that specializes in the fields of cfDNA, liquid biopsy, tumor monitoring, laboratory testing, and molecular diagnostics. its …CIRCULOGENE. Feb 2021 - Present2 years 5 months. Pensacola, Florida, United States. Creating strategic initiatives and strategies for the organization. Growing the company by leading IT and ... CIRCULOGENE is the most comprehensive blood-based approach to detecting clinically significant tumor DNA/RNA alterations. 25,000 cancer patients have benefited from our innovative, best-in-class liquid biopsy. Our novel approach has created unique …Jun 29, 2016 · Circulogene is the first and only biotechnology company able to enrich circulating cell-free DNA from blood drops for patient-specific monitoring of cancer, achieving maximal output from minimal input. CIRCULOGENE is Clinical Laboratory Improvement Amendments (CLIA) and College of American Pathologists (CAP) certified and provides biomarker testing for a broad range of cancers, allowing physicians to match results to specific drugs and clinical trials in just one week.May 26, 2021 · BIRMINGHAM, Ala.-- ( BUSINESS WIRE )-- CIRCULOGENE, an innovative molecular diagnostics company transforming precision medicine through the rapid delivery of actionable results, announced today... May 28, 2021. A local molecular diagnostic company has received a patent for its proprietary cell-free nucleic acid (CfNA) preparation mythology. Circulogene's …Circulogene also markets multiple next-generation sequencing-based tests, including one that tracks microsatellite instability (MSI) for immunotherapy, as well as DNA, RNA, somatic, and germline mutations. The tests, which the firm said can produce results in five to seven days, allow clinicians to identify patients eligible for treatment with ...46 Latest Deal Type Later Stage VC Latest Deal Amount $2M Investors 1 General Information Description Provider of molecular cancer diagnostics services intended to offer a non-invasive and cost-effective alternative for high-sensitivity monitoring across a variety of sample types. CIRCULOGENE. Feb 2021 - Present2 years 5 months. Pensacola, Florida, United States. Creating strategic initiatives and strategies for the organization. Growing the company by leading IT and ... CirculoGene is a biotechnology company that specializes in the fields of cfDNA, liquid biopsy, tumor monitoring, laboratory testing, and molecular diagnostics. its proprietary laboratory-developed test for cfDNA, cRNA, and MSI liquid biopsies, CIRCULOGENE has developed a next-generation sequencing (NGS) method to provide full genomic load analysis. kauffman building supplyus opticalplay n go Circulogene continues to collaborate with other biotechnology research institutions on additional research projects. Circulogene is the first and only biotechnology company able to enrich circulating cell-free DNA from blood drops for patient-specific monitoring of cancer, achieving maximal output from minimal input.May 28, 2021 A local molecular diagnostic company has received a patent for its proprietary cell-free nucleic acid (CfNA) preparation mythology. Circulogene's patent covers methods for the... biovation labs llc About CIRCULOGENE. Headquartered in Birmingham, Ala., CIRCULOGENE is an innovative molecular diagnostics company founded and operated by a team of experienced industry executives and skilled molecular diagnostics scientists. Applying its proprietary laboratory developed test for cfDNA, cfRNA and MSI liquid biopsies, …May 28, 2021 A local molecular diagnostic company has received a patent for its proprietary cell-free nucleic acid (CfNA) preparation mythology. Circulogene's patent covers methods for the... oneloan direct May 12, 2023 · CIRCULOGENE provides comprehensive biomarker testing for a broad range of cancers allowing physicians to match patient results with specific therapies in just one week. Their sequencing and qPCR... CIRCULOGENE. Feb 2021 - Present2 years 5 months. Pensacola, Florida, United States. Creating strategic initiatives and strategies for the organization. Growing the company by leading IT and ...Jun 17, 2019 · CIRCULOGENE – Subcontractor to U.S. Department of Defense Research Award – to Develop Liquid Biopsy Markers for Traumatic Brain Injury $1.5 Million grant to The Geneva Foundation will use CIRCULOGENE’s liquid biopsy to quickly ID and accurately quantify organ-specific injury markers for improved treatment and survival in severely wounded military and civilian personnel BIRMINGHAM, g tracCirculogene also markets multiple next-generation sequencing-based tests, including one that tracks microsatellite instability (MSI) for immunotherapy, as well as DNA, RNA, somatic, and germline mutations. The tests, which the firm said can produce results in five to seven days, allow clinicians to identify patients eligible for treatment with ...Richard A. Brand, MBA Chief Financial Officer for life science New York, New York, United States 4K followers 500+ connections Join to view profile CIRCULOGENE The University of Chicago Booth... dan pinto CIRCULOGENE provides comprehensive biomarker testing for a broad range of cancers allowing physicians to match patient results with specific therapies in just one week. Their sequencing and qPCR...May 28, 2021 A local molecular diagnostic company has received a patent for its proprietary cell-free nucleic acid (CfNA) preparation mythology. Circulogene's patent covers methods for the...NEW YORK (GenomeWeb) – With the upcoming launch of its neurotrophic receptor tyrosine kinase (NTRK) gene fusion assay, liquid biopsy firm Circulogene is …About us. Headquartered in Birmingham, Ala., CIRCULOGENE is an innovative molecular diagnostics company founded and operated by a team of experienced industry executives and skilled molecular ... napa massena ny CIRCULOGENE. Aug 2021 - Present1 year 10 months. Birmingham, Alabama, United States. Recruited a new Controller and replaced the …May 11, 2023 · CIRCULOGENE provides comprehensive biomarker testing for a broad range of cancers allowing physicians to match patient results with specific therapies in just one week. Their sequencing and qPCR... Louis Apicella COO | CTO Laboratory Operations Expertise | AI (Artificial Intelligence) Expertise | Laboratory IT Expertise | P&L Management | Operations Improvements | Strategic Planning Fort...Circulogene - Vice President of Translational Medicine Glendale, Arizona, United States. 862 followers 500+ connections. Join to view profile CIRCULOGENE. University of Arizona. Report this ... bonafide systems May 28, 2021 · May 28, 2021 A local molecular diagnostic company has received a patent for its proprietary cell-free nucleic acid (CfNA) preparation mythology. Circulogene's patent covers methods for the... May 28, 2021. A local molecular diagnostic company has received a patent for its proprietary cell-free nucleic acid (CfNA) preparation mythology. Circulogene's … mills fingerprint service May 28, 2021 · May 28, 2021 A local molecular diagnostic company has received a patent for its proprietary cell-free nucleic acid (CfNA) preparation mythology. Circulogene's patent covers methods for the... Richard A. Brand, MBA Chief Financial Officer for life science New York, New York, United States 4K followers 500+ connections Join to view profile CIRCULOGENE The University of Chicago Booth...CirculoGene Theranostics has raised a total of $9.2M in funding over 6 rounds. Their latest funding was raised on Mar 24, 2023 from a Debt Financing round. Funding Rounds. Edit Funding Rounds Section. Number of Funding Rounds 6. Total Funding Amount $9.2M. save mart distribution center Jun 1, 2018 · With the recent FDA approval of a commercially available tumor tissue NGS assay and reports of low concordance across different platforms, we sought to evaluate the concordance of DNA mutations and PD-L1 testing results from Caris Molecular Intelligence testing (CMI) or FoundationOne (F1) on tumor tissue and Circulogene Theranostics ... CIRCULOGENE provides comprehensive biomarker testing for a broad range of cancers allowing physicians to match patient results with specific therapies in just one week. Their sequencing and qPCR... milanosport spa With the recent FDA approval of a commercially available tumor tissue NGS assay and reports of low concordance across different platforms, we sought to evaluate the concordance of DNA mutations and PD-L1 testing results from Caris Molecular Intelligence testing (CMI) or FoundationOne (F1) on tumor tissue and Circulogene Theranostics ...About us. Headquartered in Birmingham, Ala., CIRCULOGENE is an innovative molecular diagnostics company founded and operated by a team of experienced industry executives and skilled molecular ... CIRCULOGENE. Feb 2021 - Present2 years 5 months. Pensacola, Florida, United States. Creating strategic initiatives and strategies for the organization. Growing the company by leading IT and ...Newly published research involving the Circulogene droplet-volume liquid biopsy test has demonstrated for the first time that circulating cell-free tumor DNA (ctDNA) sequencing can detect the presence of a new tumor mass earlier than current, standard-of-care imaging methods. Additionally, research presented at the American Society of …Circulogene also markets multiple next-generation sequencing-based tests, including one that tracks microsatellite instability (MSI) for immunotherapy, as well as DNA, RNA, somatic, and germline mutations. The tests, which the firm said can produce results in five to seven days, allow clinicians to identify patients eligible for treatment with ... berkley north pacific May 28, 2021 A local molecular diagnostic company has received a patent for its proprietary cell-free nucleic acid (CfNA) preparation mythology. Circulogene's patent covers methods for the... everett boeing phone number Circulogene also markets multiple next-generation sequencing-based tests, including one that tracks microsatellite instability (MSI) for immunotherapy, as well as DNA, RNA, somatic, and germline mutations. The tests, which the firm said can produce results in five to seven days, allow clinicians to identify patients eligible for treatment with ...CIRCULOGENE provides comprehensive biomarker testing for a broad range of cancers allowing physicians to match patient results with specific therapies in just one week. Their sequencing and qPCR...Using just a single tube of blood, CIRCULOGENE is able to test for circulating genetic mutations and tumor biomarkers among DNA mutations, RNA …CIRCULOGENE 8 years 5 months Co-Founder, Chief Administrative Officer Oct 2021 - Present1 year 8 months Birmingham, Alabama Area bp lubricants CirculoGene is a biotechnology company that specializes in the fields of cfDNA, liquid biopsy, tumor monitoring, laboratory testing, and molecular diagnostics. its proprietary laboratory-developed test for cfDNA, cRNA, and MSI liquid biopsies, CIRCULOGENE has developed a next-generation sequencing (NGS) method to provide full genomic load analysis.May 25, 2020 · Background: Programmed death ligand-1 (PD-L1) protein expression by immunohistochemical staining (IHC) correlates with response to immune checkpoint inhibitor (ICI) therapies in non-small cell lung cancer (NSCLC). Tumor mutational burden (TMB) is another immune biomarker of ICI response in NSCLC. Jun 17, 2019 · CIRCULOGENE is Clinical Laboratory Improvement Amendments (CLIA) and College of American Pathologists (CAP) certified and provides biomarker testing for a broad range of cancers, allowing physicians to match results to specific drugs and clinical trials in just one week. smartscripts CIRCULOGENE 8 years 5 months Co-Founder, Chief Administrative Officer Oct 2021 - Present1 year 8 months Birmingham, Alabama AreaCIRCULOGENE provides the most enhanced MSI detection available. MSI-high could be an indication of immunotherapy response in colorectal cancer. More InformationCIRCULOGENE is a Clinical Laboratory Improvement Amendments (CLIA) and College of American Pathologists (CAP) certified laboratory and a Verified Vendor for the federal System for Award Management ...CIRCULOGENE. Aug 2021 - Present1 year 10 months. Birmingham, Alabama, United States. Recruited a new Controller and replaced the entire Accounting Department. Lead improvement in financial ... alert enterprise Sep 28, 2022 · Circulogene is a provider established in Pensacola, Florida operating as a Clinical Medical Laboratory. The NPI number of this provider is 1780308262 and was assigned on September 2022. The practitioner's primary taxonomy code is 291U00000X. The provider is registered as an organization and their NPI record was last updated April 2023. Richard A. Brand, MBA Chief Financial Officer for life science New York, New York, United States 4K followers 500+ connections Join to view profile CIRCULOGENE The University of Chicago Booth...Headquartered in Birmingham, Ala., CIRCULOGENE is an innovative molecular diagnostics company founded and operated by a team of experienced industry executives and skilled molecular diagnostics ... tartle If you're a small business in need of assistance, please contact [email protected]
Richard A. Brand, MBA Chief Financial Officer for life science New York, New York, United States 4K followers 500+ connections Join to view profile CIRCULOGENE The University of Chicago Booth... streamset CIRCULOGENE, an innovative molecular diagnostics company transforming precision medicine through the rapid delivery of actionable results, announced today that the United States Patent and Trademark Office has issued U.S. Patent No. 11,015,213 for its proprietary cell-free nucleic acid (cfNA) preparation methodology. The patent, titled “ …Jun 17, 2019 · CIRCULOGENE is Clinical Laboratory Improvement Amendments (CLIA) and College of American Pathologists (CAP) certified and provides biomarker testing for a broad range of cancers, allowing physicians to match results to specific drugs and clinical trials in just one week. Newly published research involving the Circulogene droplet-volume liquid biopsy test has demonstrated for the first time that circulating cell-free tumor DNA (ctDNA) sequencing can detect the presence of a new tumor mass earlier than current, standard-of-care imaging methods. Additionally, research presented at the American Society of …Newly published research involving the Circulogene droplet-volume liquid biopsy test has demonstrated for the first time that circulating cell-free tumor DNA (ctDNA) sequencing can detect the presence of a new tumor mass earlier than current, standard-of-care imaging methods. Additionally, research presented at the American Society of … circle k phoenix Richard A. Brand, MBA Chief Financial Officer for life science New York, New York, United States 4K followers 500+ connections Join to view profile CIRCULOGENE The University of Chicago Booth...BIRMINGHAM, Ala.-- ( BUSINESS WIRE )-- CIRCULOGENE, an innovative molecular diagnostics company transforming precision medicine through the rapid delivery of actionable results, announced today...CIRCULOGENE is the most comprehensive blood-based approach to detecting clinically significant tumor DNA/RNA alterations. 25,000 cancer patients have benefited from our innovative, best-in-class liquid biopsy. Our novel approach has created unique liquid biopsy tests which aids oncologists to personalize and monitor the patient’s treatment ... international leasing co inc Richard A. Brand, MBA Chief Financial Officer for life science New York, New York, United States 4K followers 500+ connections Join to view profile CIRCULOGENE The University of Chicago Booth...With the recent FDA approval of a commercially available tumor tissue NGS assay and reports of low concordance across different platforms, we sought to evaluate the concordance of DNA mutations and PD-L1 testing results from Caris Molecular Intelligence testing (CMI) or FoundationOne (F1) on tumor tissue and Circulogene Theranostics ... county concrete corporation CIRCULOGENE. Feb 2021 - Present2 years 5 months. Pensacola, Florida, United States. Creating strategic initiatives and strategies for the organization. Growing the company by leading IT and ...Circulogene is a provider established in Pensacola, Florida operating as a Clinical Medical Laboratory. The NPI number of this provider is 1780308262 and was assigned on September 2022. The practitioner's primary taxonomy code is 291U00000X. The provider is registered as an organization and their NPI record was last updated April 2023. solutions by the sea CIRCULOGENE is a Clinical Laboratory Improvement Amendments (CLIA) and College of American Pathologists (CAP) certified laboratory and a Verified Vendor for the federal System for Award Management.CIRCULOGENE is Clinical Laboratory Improvement Amendments (CLIA) and College of American Pathologists (CAP) certified and provides biomarker testing for a broad range of cancers, allowing physicians to match results to specific drugs and clinical trials in just one week.CIRCULOGENE, an innovative molecular diagnostics company transforming precision medicine through the rapid delivery of actionable results, announced today that the United States Patent and Trademark Office has issued U.S. Patent No. 11,015,213 for its proprietary cell-free nucleic acid (cfNA) preparation methodology. The patent, titled “ …Jun 17, 2019 · CIRCULOGENE – Subcontractor to U.S. Department of Defense Research Award – to Develop Liquid Biopsy Markers for Traumatic Brain Injury $1.5 Million grant to The Geneva Foundation will use... bank north casselton nd46 Latest Deal Type Later Stage VC Latest Deal Amount $2M Investors 1 General Information Description Provider of molecular cancer diagnostics services intended to offer a non-invasive and cost-effective alternative for high-sensitivity monitoring across a variety of sample types. (205) 521-8151 Company Circulogene Louis Apicella Current Workplace Louis Apicella has been working as a Chief Operations Officer at Circulogene for 2 years. Circulogene is part of the Business Services industry, and located in Alabama, United States. Circulogene Location 3125 Independence Dr Ste 301, Birmingham, Alabama, 35209, United States sandsrx CIRCULOGENE is Clinical Laboratory Improvement Amendments (CLIA) and College of American Pathologists (CAP) certified and provides biomarker testing for a broad range of cancers, allowing physicians to match results to specific drugs and clinical trials in just one week.CIRCULOGENE is Clinical Laboratory Improvement Amendments (CLIA) certified and provides biomarker testing for a broad range of cancers, allowing physicians to match results to specific drugs and... 3778 CIRCULOGENE is the most comprehensive blood-based approach to detecting clinically significant tumor DNA/RNA alterations. 25,000 cancer patients have benefited from our innovative, best-in-class liquid biopsy. Our novel approach has created unique liquid biopsy tests which aids oncologists to personalize and monitor the patient’s treatment ...May 11, 2023 · CIRCULOGENE provides comprehensive biomarker testing for a broad range of cancers allowing physicians to match patient results with specific therapies in just one week. Their sequencing and qPCR... CIRCULOGENE is a Clinical Laboratory Improvement Amendments (CLIA) and College of American Pathologists (CAP) certified laboratory and a Verified Vendor for the federal System for Award Management. christman screenprint CIRCULOGENE's blood-based, gene panel is central to research presented at last weekend's Digestive Disease Week 2023. Speed of delivery resulting from liquid …CIRCULOGENE. Aug 2021 - Present1 year 10 months. Birmingham, Alabama, United States. Recruited a new Controller and replaced the entire Accounting Department. Lead improvement in financial ... 46 Latest Deal Type Later Stage VC Latest Deal Amount $2M Investors 1 General Information Description Provider of molecular cancer diagnostics services intended to offer a non-invasive and cost-effective alternative for high-sensitivity monitoring across a variety of sample types. 333 seats CIRCULOGENE provides comprehensive biomarker testing for a broad range of cancers, allowing physicians to match patient results with specific therapies in just one week. The company has developed proprietary enrichment technology to minimize genetic data loss, so t Read More Contact Who is Circulogene Headquarters List of tyrosine kinase inhibitors approved by FDA for this indication: Tarceva (erlotinib) - NDA 021743. Tagrisso (osimertinib) - NDA 208065. Iressa (gefitinib) - NDA 206995. ONCO/Reveal Dx Lung ...May 28, 2021 · May 28, 2021 A local molecular diagnostic company has received a patent for its proprietary cell-free nucleic acid (CfNA) preparation mythology. Circulogene's patent covers methods for the... BIRMINGHAM, Ala.-- ( BUSINESS WIRE )-- CIRCULOGENE, an innovative molecular diagnostics company transforming precision medicine through the rapid delivery of actionable results, announced today... grow more inc Jun 29, 2016 · Circulogene is the first and only biotechnology company able to enrich circulating cell-free DNA from blood drops for patient-specific monitoring of cancer, achieving maximal output from minimal input. About us. Headquartered in Birmingham, Ala., CIRCULOGENE is an innovative molecular diagnostics company founded and operated by a team of experienced industry executives and skilled molecular ...Address: 3125 Independence Dr Ste 301 Homewood, AL, 35209-4165 United States Phone: intercos Apr 8, 2022 · 3125 Independence Dr.,, Suite 301 Homewood, Alabama, United States 35209 Phone: 205-278-1600 Fax: 205-278-1651 Email: [email protected] Online Contact: http://circulogene.com/contact/ Website: http://circulogene.com/ GTR Lab ID: 505758, Last updated:2022-04-08 Personnel Director: Chen-Hsiung Yeh, PhD, Lab Associate Director Phone: 205-278-1608 CIRCULOGENE is a Clinical Laboratory Improvement Amendments (CLIA) and College of American Pathologists (CAP) certified laboratory and a Verified Vendor for the federal System for Award Management ... breakers unlimited With the recent FDA approval of a commercially available tumor tissue NGS assay and reports of low concordance across different platforms, we sought to evaluate the concordance of DNA mutations and PD-L1 testing results from Caris Molecular Intelligence testing (CMI) or FoundationOne (F1) on tumor tissue and Circulogene Theranostics ...Circulogene also markets multiple next-generation sequencing-based tests, including one that tracks microsatellite instability (MSI) for immunotherapy, as well as DNA, RNA, somatic, and germline mutations. The tests, which the firm said can produce results in five to seven days, allow clinicians to identify patients eligible for treatment with ... spoon university Circulogene’s “liquid biopsy” is based on the discovery that as tumors grow, they also die, releasing their DNA into the bloodstream. Circulogene’s liquid biopsy tumor DNA sequencing is the only test available that combines finger stick volumes of blood and the most advanced next-generation sequencing (NGS) to monitor tumor mutant DNA ...46 Latest Deal Type Later Stage VC Latest Deal Amount $2M Investors 1 General Information Description Provider of molecular cancer diagnostics services intended to offer a non-invasive and cost-effective alternative for high-sensitivity monitoring across a variety of sample types. Richard A. Brand, MBA Chief Financial Officer for life science New York, New York, United States 4K followers 500+ connections Join to view profile CIRCULOGENE The University of Chicago Booth... CIRCULOGENE is Clinical Laboratory Improvement Amendments (CLIA) certified and provides biomarker testing for a broad range of cancers, allowing physicians to match results to specific drugs and...NEW YORK (GenomeWeb) – With the upcoming launch of its neurotrophic receptor tyrosine kinase (NTRK) gene fusion assay, liquid biopsy firm Circulogene is … nc inc Jun 17, 2019 · CIRCULOGENE – Subcontractor to U.S. Department of Defense Research Award – to Develop Liquid Biopsy Markers for Traumatic Brain Injury $1.5 Million grant to The Geneva Foundation will use... Circulogene DNA Testing Kit Review. Circulogene was formed with an aim to improve cancer treatments, citing the statistic on its website that 1,600 people die of cancer every …CIRCULOGENE. Aug 2021 - Present1 year 10 months. Birmingham, Alabama, United States. Recruited a new Controller and replaced the …CIRCULOGENE is a Clinical Laboratory Improvement Amendments (CLIA) and College of American Pathologists (CAP) certified laboratory and a Verified Vendor for the federal System for Award Management ... marco crane Newly published research involving the Circulogene droplet-volume liquid biopsy test has demonstrated for the first time that circulating cell-free tumor DNA (ctDNA) sequencing can detect the presence of a new tumor mass earlier than current, standard-of-care imaging methods. Additionally, research presented at the American Society of …3125 Independence Dr.,, Suite 301 Homewood, Alabama, United States 35209 Phone: 205-278-1600 Fax: 205-278-1651 Email: [email protected] Online Contact: http://circulogene.com/contact/ Website: http://circulogene.com/ GTR Lab ID: 505758, Last updated:2022-04-08 Personnel Director: Chen-Hsiung Yeh, PhD, Lab Associate Director Phone: 205-278-1608About us. Headquartered in Birmingham, Ala., CIRCULOGENE is an innovative molecular diagnostics company founded and operated by a team of experienced industry executives and skilled molecular ... rentomojo BIRMINGHAM, Ala. and PENSACOLA, Fla. (PRWEB) May 11, 2023. CIRCULOGENE is an innovative medical technology company transforming precision medicine through the rapid delivery of actionable results. Their blood-based, 88-gene panel, used for detecting circulating tumor DNA (ctDNA), was featured in the research study “Analysis of Circulating ...Louis Apicella COO | CTO Laboratory Operations Expertise | AI (Artificial Intelligence) Expertise | Laboratory IT Expertise | P&L Management | Operations Improvements | Strategic Planning Fort... regaming Sep 28, 2022 · Circulogene is a provider established in Pensacola, Florida operating as a Clinical Medical Laboratory. The NPI number of this provider is 1780308262 and was assigned on September 2022. The practitioner's primary taxonomy code is 291U00000X. The provider is registered as an organization and their NPI record was last updated April 2023. jandj titusville nj May 12, 2023 · CIRCULOGENE provides comprehensive biomarker testing for a broad range of cancers allowing physicians to match patient results with specific therapies in just one week. Their sequencing and qPCR... Circulogene is the first and only biotechnology company able to enrich circulating cell-free DNA from blood drops for patient-specific monitoring of cancer, achieving maximal output from minimal input.Jun 17, 2019 · CIRCULOGENE is Clinical Laboratory Improvement Amendments (CLIA) and College of American Pathologists (CAP) certified and provides biomarker testing for a broad range of cancers, allowing physicians to match results to specific drugs and clinical trials in just one week. 3125 Independence Dr.,, Suite 301 Homewood, Alabama, United States 35209 Phone: 205-278-1600 Fax: 205-278-1651 Email: [email protected] Online Contact: http://circulogene.com/contact/ Website: http://circulogene.com/ GTR Lab ID: 505758, Last updated:2022-04-08 Personnel Director: Chen-Hsiung Yeh, PhD, Lab Associate Director Phone: 205-278-1608 willis supply
Solutions from Circulogene, Inc. Yellow Pages directories can mean big success stories for your. circulogene White Pages are public records which are documents or pieces of information that are not considered confidential and can be viewed instantly online. me/circulogene If you're a small business in need of assistance, please contact [email protected]